Owen, Thomas J., O'Neil, John D., Dawson, Christopher W., Hu, Chunfang, Chen, Xiaoyi, Yao, Yunhong, Wood, Victoria H. J., Mitchell, Louise E., White, Robert J., 1963-, Young, Lawrence S. and Arrand, J. R. (John R.). (2010) Epstein-Barr virus-encoded EBNA1 enhances RNA polymerase III-dependent EBER expression through induction of EBER-associated cellular transcription factors. Molecular Cancer, Vol.9 (No.1). p. 241. ISSN 1476-4598

Preview

Text WRAP_Young_1476-4598-9-241.pdf - Published Version Download (1915Kb) | Preview

Abstract

Background Epstein-Barr Virus (EBV)-encoded RNAs (EBERs) are non-polyadenylated RNA molecules transcribed from the EBV genome by RNA polymerase III (pol III). EBERs are the most abundant viral latent gene products, although the precise mechanisms by which EBV is able to achieve such high levels of EBER expression are not fully understood. Previously EBV has been demonstrated to induce transcription factors associated with EBER expression, including pol III transcription factors and ATF-2. We have recently demonstrated that EBV-encoded nuclear antigen-1 (EBNA1) induces cellular transcription factors, and given these findings, we investigated the role of EBNA1 in induction of EBER-associated transcription factors. Results Our data confirm that in epithelial cells EBNA1 can enhance cellular pol III transcription. Transient expression of EBNA1 in Ad/AH cells stably expressing the EBERs led to induction of both EBER1 and EBER2 and conversely, expression of a dominant negative EBNA1 led to reduced EBER expression in EBV-infected Ad/AH cells. EBNA1 can induce transcription factors used by EBER genes, including TFIIIC, ATF-2 and c-Myc. A variant chromatin precipitation procedure showed that EBNA1 is associated with the promoters of these genes but not with the promoters of pol III-transcribed genes, including the EBERs themselves. Using shRNA knock-down, we confirm the significance of both ATF-2 and c-Myc in EBER expression. Further, functional induction of a c-Myc fusion protein led to increased EBER expression, providing c-Myc binding sites upstream of EBER1 were intact. In vivo studies confirm elevated levels of the 102 kD subunit of TFIIIC in the tumour cells of EBV-positive nasopharyngeal carcinoma biopsies. Conclusions Our findings reveal that EBNA1 is able to enhance EBER expression through induction of cellular transcription factors and add to the repertoire of EBNA1's transcription-regulatory properties.

Item Type:	Journal Article
Subjects:	Q Science > QR Microbiology > QR355 Virology
Divisions:	Faculty of Medicine > Warwick Medical School
Library of Congress Subject Headings (LCSH):	Epstein-Barr virus -- Genetic aspects
Journal or Publication Title:	Molecular Cancer
Publisher:	BioMed Central Ltd.
ISSN:	1476-4598
Date:	15 September 2010
Volume:	Vol.9
Number:	No.1
Page Range:	p. 241
Identification Number:	10.1186/1476-4598-9-241
Status:	Peer Reviewed
Publication Status:	Published
Access rights to Published version:	Open Access
Funder:	Cancer Research UK (CRUK)
References:	1. Young LS, Rickinson AB: Epstein-Barr virus: 40 years on. Nat Rev Cancer 2004, 4:757-768. 2. Laing KG, Elia A, Jeffrey I, Matys V, Tilleray VJ, Souberbielle B, Clemens MJ: In vivo effects of the Epstein-Barr virus small RNA EBER-1 on protein synthesis and cell growth regulation. Virology 2002, 297:253-269. 3. Laing KG, Matys V, Clemens JM: Effects of expression of the Epstein-Barr virus small RNA EBER-1 in heterologous cells on protein synthesis and cell growth. Biochem Soc Trans 1995, 23:311S. 4. Ruf IK, Rhyne PW, Yang C, Cleveland JL, Sample JT: Epstein-Barr virus small RNAs potentiate tumorigenicity of Burkitt lymphoma cells independently of an effect on apoptosis. J Virol 2000, 74:10223-10228. 5. Zeuthen J: Epstein-Barr virus (EBV), lymphocytes and transformation. J Cancer Res Clin Oncol 1983, 106:1-11. 6. Clarke PA, Schwemmle M, Schickinger J, Hilse K, Clemens MJ: Binding of Epstein-Barr virus small RNA EBER-1 to the double-stranded RNAactivated protein kinase DAI. Nucleic Acids Res 1991, 19:243-248. 7. Nanbo A, Inoue K, Adachi-Takasawa K, Takada K: Epstein-Barr virus RNA confers resistance to interferon-alpha-induced apoptosis in Burkitt’s lymphoma. EMBO J 2002, 21:954-965. 8. Samanta M, Iwakiri D, Kanda T, Imaizumi T, Takada K: EB virus-encoded RNAs are recognized by RIG-I and activate signaling to induce type I IFN. EMBO J 2006, 25:4207-4214. 9. Lerner MR, Andrews NC, Miller G, Steitz JA: Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus. Proc Natl Acad Sci USA 1981, 78:805-809. 10. Fok V, Mitton-Fry RM, Grech A, Steitz JA: Multiple domains of EBER 1, an Epstein-Barr virus noncoding RNA, recruit human ribosomal protein L22. RNA 2006, 12:872-882. 11. Toczyski DP, Matera AG, Ward DC, Steitz JA: The Epstein-Barr virus (EBV) small RNA EBER1 binds and relocalizes ribosomal protein L22 in EBVinfected human B lymphocytes. Proc Natl Acad Sci USA 1994, 91:3463-3467. 12. Houmani JL, Davis CI, Ruf IK: Growth-promoting properties of Epstein-Barr virus EBER-1 RNA correlate with ribosomal protein L22 binding. J Virol 2009, 83:9844-9853. 13. Kitagawa N, Goto M, Kurozumi K, Maruo S, Fukayama M, Naoe T, Yasukawa M, Hino K, Suzuki T, Todo S, Takada K: Epstein-Barr virusencoded poly(A)(-) RNA supports Burkitt’s lymphoma growth through interleukin-10 induction. EMBO J 2000, 19:6742-6750. 14. Yang L, Aozasa K, Oshimi K, Takada K: Epstein-Barr virus (EBV)-encoded RNA promotes growth of EBV-infected T cells through interleukin-9 induction. Cancer Res 2004, 64:5332-5337. 15. Iwakiri D, Eizuru Y, Tokunaga M, Takada K: Autocrine growth of Epstein- Barr virus-positive gastric carcinoma cells mediated by an Epstein-Barr virus-encoded small RNA. Cancer Res 2003, 63:7062-7067. 16. Iwakiri D, Sheen TS, Chen JY, Huang DP, Takada K: Epstein-Barr virusencoded small RNA induces insulin-like growth factor 1 and supports growth of nasopharyngeal carcinoma-derived cell lines. Oncogene 2005, 24:1767-1773. 17. Wong HL, Wang X, Chang RC, Jin DY, Feng H, Wang Q, Lo KW, Huang DP, Yuen PW, Takada K, Wong YC, Tsao SW: Stable expression of EBERs in immortalized nasopharyngeal epithelial cells confers resistance to apoptotic stress. Mol Carcinog 2005, 44:92-101. 18. Arrand JR, Rymo L: Characterization of the major Epstein-Barr virusspecific RNA in Burkitt lymphoma-derived cells. J Virol 1982, 41:376-389. 19. Rosa MD, Gottlieb E, Lerner MR, Steitz JA: Striking similarities are exhibited by two small Epstein-Barr virus-encoded ribonucleic acids and the adenovirus-associated ribonucleic acids VAI and VAII. Mol Cell Biol 1981, 1:785-796. 20. Howe JG, Shu MD: Epstein-Barr virus small RNA (EBER) genes: unique transcription units that combine RNA polymerase II and III promoter elements. Cell 1989, 57:825-834. 21. Niller HH, Salamon D, Ilg K, Koroknai A, Banati F, Bauml G, Rucker O, Schwarzmann F, Wolf H, Minarovits J: The in vivo binding site for oncoprotein c-Myc in the promoter for Epstein-Barr virus (EBV) encoding RNA (EBER) 1 suggests a specific role for EBV in lymphomagenesis. Med Sci Monit 2003, 9:HY1-9. 22. Felton-Edkins ZA, White RJ: Multiple mechanisms contribute to the activation of RNA polymerase III transcription in cells transformed by papovaviruses. J Biol Chem 2002, 277:48182-48191. 23. Gottesfeld JM, Johnson DL, Nyborg JK: Transcriptional activation of RNA polymerase III-dependent genes by the human T-cell leukemia virus type 1 tax protein. Mol Cell Biol 1996, 16:1777-1785. 24. Hoeffler WK, Kovelman R, Roeder RG: Activation of transcription factor IIIC by the adenovirus E1A protein. Cell 1988, 53:907-920. 25. Larminie CG, Sutcliffe JE, Tosh K, Winter AG, Felton-Edkins ZA, White RJ: Activation of RNA polymerase III transcription in cells transformed by simian virus 40. Mol Cell Biol 1999, 19:4927-4934. 26. Wang HD, Trivedi A, Johnson DL: Hepatitis B virus X protein induces RNA polymerase III-dependent gene transcription and increases cellular TATA-binding protein by activating the Ras signaling pathway. Mol Cell Biol 1997, 17:6838-6846. 27. Greifenegger N, Jager M, Kunz-Schughart LA, Wolf H, Schwarzmann F: Epstein-Barr virus small RNA (EBER) genes: differential regulation during lytic viral replication. J Virol 1998, 72:9323-9328. 28. Rooney C, Howe JG, Speck SH, Miller G: Influence of Burkitt’s lymphoma and primary B cells on latent gene expression by the nonimmortalizing P3J-HR-1 strain of Epstein-Barr virus. J Virol 1989, 63:1531-1539. 29. Felton-Edkins ZA, Kondrashov A, Karali D, Fairley JA, Dawson CW, Arrand JR, Young LS, White RJ: Epstein-Barr virus induces cellular transcription factors to allow active expression of EBER genes by RNA polymerase III. J Biol Chem 2006, 281:33871-33880. 30. Alfieri C, Birkenbach M, Kieff E: Early events in Epstein-Barr virus infection of human B lymphocytes. Virology 1991, 181:595-608. 31. O’Neil JD, Owen TJ, Wood VH, Date KL, Valentine R, Chukwuma MB, Arrand JR, Dawson CW, Young LS: Epstein-Barr virus-encoded EBNA1 modulates the AP-1 transcription factor pathway in nasopharyngeal carcinoma cells and enhances angiogenesis in vitro. J Gen Virol 2008, 89:2833-2842. 32. Gahn TA, Sugden B: An EBNA-1-dependent enhancer acts from a distance of 10 kilobase pairs to increase expression of the Epstein-Barr virus LMP gene. J Virol 1995, 69:2633-2636. 33. Sample J, Henson EB, Sample C: The Epstein-Barr virus nuclear protein 1 promoter active in type I latency is autoregulated. J Virol 1992, 66:4654-4661. 34. Sugden B, Warren N: A promoter of Epstein-Barr virus that can function during latent infection can be transactivated by EBNA-1, a viral protein required for viral DNA replication during latent infection. J Virol 1989, 63:2644-2649. 35. Wood VH, O’Neil JD, Wei W, Stewart SE, Dawson CW, Young LS: Epstein- Barr virus-encoded EBNA1 regulates cellular gene transcription and modulates the STAT1 and TGFbeta signaling pathways. Oncogene 2007, 26:4135-4147. 36. Mrazek J, Kreutmayer SB, Grasser FA, Polacek N, Huttenhofer A: Subtractive hybridization identifies novel differentially expressed ncRNA species in EBV-infected human B cells. Nucleic Acids Res 2007, 35:e73. 37. Nandy C, Mrázek J, Stoiber H, Grässer FA, Hüttenhofer A, Polacek N: Epstein-Barr virus-induced expression of a novel human vault RNA. J Mol Biol 2009, 388:776-784. 38. Marshall L, Kenneth NS, White RJ: Elevated tRNA(iMet) synthesis can drive cell proliferation and oncogenic transformation. Cell 2008, 133:78-89. 39. Chau CM, Lieberman PM: Dynamic chromatin boundaries delineate a latency control region of Epstein-Barr virus. J Virol 2004, 78:12308-12319. 40. Ambinder RF, Shah WA, Rawlins DR, Hayward GS, Hayward SD: Definition of the sequence requirements for binding of the EBNA-1 protein to its palindromic target sites in Epstein-Barr virus DNA. J Virol 1990, 64:2369-2379. 41. Gomez-Roman N, Grandori C, Eisenman RN, White RJ: Direct activation of RNA polymerase III transcription by c-Myc. Nature 2003, 421:290-294. 42. Chen W, Bocker W, Brosius J, Tiedge H: Expression of neural BC200 RNA in human tumours. J Pathol 1997, 183:345-351. 43. Marshall L, White RJ: Non-coding RNA production by RNA polymerase III is implicated in cancer. Nat Rev Cancer 2008, 8:911-914. 44. White RJ: RNA polymerases I and III, non-coding RNAs and cancer. Trends Genet 2008, 24:622-629. 45. Johnson SA, Dubeau L, Johnson DL: Enhanced RNA polymerase IIIdependent transcription is required for oncogenic transformation. J Biol Chem 2008, 283:19184-19191. 46. Howe JG, Shu MD: Upstream basal promoter element important for exclusive RNA polymerase III transcription of the EBER 2 gene. Mol Cell Biol 1993, 13:2655-2665. 47. Wensing B, Stuhler A, Jenkins P, Hollyoake M, Karstegl CE, Farrell PJ: Variant chromatin structure of the oriP region of Epstein-Barr virus and regulation of EBER1 expression by upstream sequences and oriP. J Virol 2001, 75:6235-6241. 48. Adamson AL, Darr D, Holley-Guthrie E, Johnson RA, Mauser A, Swenson J, Kenney S: Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 activate the ATF2 transcription factor by increasing the levels of phosphorylated p38 and c-Jun N-terminal kinases. J Virol 2000, 74:1224-1233. 49. Eliopoulos AG, Young LS: Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1). Oncogene 1998, 16:1731-42. 50. Kieser A, Kilger E, Gires O, Ueffing M, Kolch W, Hammerschmidt W: Epstein- Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade. EMBO J 1997, 16:6478-6485. 51. Roberts ML, Cooper NR: Activation of a ras-MAPK-dependent pathway by Epstein-Barr virus latent membrane protein 1 is essential for cellular transformation. Virology 1998, 240:93-99. 52. Canaan A, Haviv I, Urban AE, Schulz VP, Hartman S, Zhang Z, Palejev D, Deisseroth AB, Lacy J, Snyder M, Gerstein M, Weissman SM: EBNA1 regulates cellular gene expression by binding cellular promoters. Proc Natl Acad Sci USA 2009, 106(52):22421-6. 53. Dresang LR, Vereide DT, Sugden B: Identifying sites bound by Epstein-Barr virus nuclear antigen 1 (EBNA1) in the human genome: defining a position-weighted matrix to predict sites bound by EBNA1 in viral genomes. J Virol 2009, 83:2930-2940. 54. Henderson A, Ripley S, Heller M, Kieff E: Chromosome site for Epstein-Barr virus DNA in a Burkitt tumor cell line and in lymphocytes growthtransformed in vitro. Proc Natl Acad Sci USA 1983, 80:1987-1991. 55. Arrand JR: Expressed but Enigmatic RNAs. Epstein-Barr Virus Report 2000, 7:145-149. 56. Marechal V, Dehee A, Chikhi-Brachet R, Piolot T, Coppey-Moisan M, Nicolas JC: Mapping EBNA-1 domains involved in binding to metaphase chromosomes. J Virol 1999, 73:4385-4392. 57. Littlewood TD, Hancock DC, Danielian PS, Parker MG, Evan GI: A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res 1995, 23:1686-1690. 58. Chen X, Arrand JR: Establishment of a cell line producing a recombinant Epstein-Barr Virus expressing GFP. Chinese Journal of Microbiology and Immunology 2003, 23:87-90. 59. Yao Y, Minter HA, Chen X, Reynolds GM, Bromley M, Arrand JR: Heterogeneity of HLA and EBER expression in Epstein-Barr virusassociated nasopharyngeal carcinoma. Int J Cancer 2000, 88:949-955. 60. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408. 61. Morris MA, Dawson CW, Wei W, O’Neil JD, Stewart SE, Jia J, Bell AI, Young LS, Arrand JR: Epstein-Barr virus-encoded LMP1 induces a hyperproliferative and inflammatory gene expression programme in cultured keratinocytes. J Gen Virol 2008, 89:2806-2820. 62. Goodfellow SJ, Graham EL, Kantidakis T, Marshall L, Coppins BA, Oficjalska- Pham D, Gerard M, Lefebvre O, White RJ: Regulation of RNA polymerase III transcription by Maf1 in mammalian cells. J Mol Biol 2008, 378:481-491.
URI:	http://wrap.warwick.ac.uk/id/eprint/51854

Request changes to a record

Actions (login required)

View Item